AS
Abdul Salam Ameerali
About Abdul Salam Ameerali
Data last updated:
Abdul Salam Ameerali is a Director at Hindustan Pharma Distributors Private Limited (since 2021), Director at Sri Sainatha Multispeciality Hospitals Private Limited (since 2021) and Director at Dm Med City Hospitals (India) Private Limited (since 2021), and holds 9 more current directorships. The companies operate in Pharma, Healthcare and Infrastructure and Utilities. The 8 current companies with reported revenue have a combined latest revenue of ₹307 Cr; the largest is Hindustan Pharma Distributors Private Limited at ₹135 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Oct 2021 | 2021 | ₹135 Cr (FY 2025) | Active | |
| Director | 08 Nov 2021 | 2007 | ₹74.74 Cr (FY 2025) | Active | |
| Director | 10 Sep 2021 | 2009 | ₹55.22 Cr (FY 2023) | Active | |
| Designated Partner | 03 Sep 2021 | 2019 | ₹39.44 Cr (FY 2021) | Active | |
| Director | 02 Sep 2021 | 2008 | ₹71.1 Lakh (FY 2023) | Active | |
| Director | 21 May 2018 | 2010 | ₹58.1 Lakh (FY 2022) | Active | |
| Director | 10 Sep 2021 | 2021 | ₹53 Lakh (FY 2024) | Active | |
| Director | 10 Sep 2021 | 2010 | ₹16.1 Lakh (FY 2025) | Active |
Board colleagues of Abdul Salam Ameerali
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abdul Salam Ameerali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abdul Salam Ameerali
Abdul Salam Ameerali currently holds 12 directorships: Hindustan Pharma Distributors Private Limited (Director, since 20 Oct 2021, revenue ₹135 Cr (FY 2025)); Sri Sainatha Multispeciality Hospitals Private Limited (Director, since 08 Nov 2021, revenue ₹74.74 Cr (FY 2025)); Dm Med City Hospitals (India) Private Limited (Director, since 10 Sep 2021, revenue ₹55.22 Cr (FY 2023)); Aster Clinical Lab Llp (Designated Partner, since 03 Sep 2021, revenue ₹39.44 Cr (FY 2021)); Ambady Infrastructure Private Limited (Director, since 02 Sep 2021, revenue ₹71.1 Lakh (FY 2023)); and 7 more.
Abdul Salam Ameerali was first appointed on 21 May 2018 as Director at Emed Human Resources India Private Limited. The most recent appointment on record is 28 Jul 2025 at Aster Dm Super-Specialty Hospital (Yeswanthpur) Private Limited.
The 8 current companies of Abdul Salam Ameerali that report revenue have a combined latest revenue of ₹307 Cr: Hindustan Pharma Distributors Private Limited ₹135 Cr (FY 2025); Sri Sainatha Multispeciality Hospitals Private Limited ₹74.74 Cr (FY 2025); Dm Med City Hospitals (India) Private Limited ₹55.22 Cr (FY 2023); Aster Clinical Lab Llp ₹39.44 Cr (FY 2021); Ambady Infrastructure Private Limited ₹71.1 Lakh (FY 2023); and 3 more.
The current boards of Abdul Salam Ameerali's companies include Abdurahman Kartholiparamba (Hindustan Pharma Distributors Private Limited), Amit Kumar (Hindustan Pharma Distributors Private Limited), Kasim Kanikkudiyil Latheef (Hindustan Pharma Distributors Private Limited), Nerendranath Venkatachala (Hindustan Pharma Distributors Private Limited), Maheshwarappa Revakka Sunil Kumar (Sri Sainatha Multispeciality Hospitals Private Limited), Wilson Joseph Thadathil (Sri Sainatha Multispeciality Hospitals Private Limited), among others.